Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Termino C 14642 AB
AB
Dissolved
Org 5592301377
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Termino C 14642 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2020
0M
2021
1M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 956
200
660
691
364
Staff expenses
—
—
−643
−62
−199
EBITDA
1 257
−265
−234
238
−157
Depreciation & amort.
−0
−0
—
−1
−7
EBIT
1 257
−265
−234
237
−164
Net financials
−5
—
0
11
10
Profit before tax
931
−30
−149
211
−116
Tax
−206
−0
—
−24
—
Net profit
725
−30
−149
187
−116
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 347
544
695
757
353
Equity
775
375
226
413
147
Long-term debt
0
0
—
—
—
Short-term debt
252
84
469
306
206
Total debt
252
84
469
306
206
Financial ratios
5-year trend
EBITDA-margin
-43.2%
This company
15.8%
Market median
-373% vs market
2020
2024
Soliditetsgrad
41.6%
This company
38.2%
Market median
+9% vs market
2020
2024
Egenkapitalforrentning
-79.1%
This company
18.4%
Market median
-530% vs market
2020
2024
Nettoresultatgrad
-31.9%
This company
8.1%
Market median
-494% vs market
2020
2024
Aktivomsætning
1.03×
This company
1.12×
Market median
+8% vs market
2020
2024
Gæld/egenkapital
1.40×
This company
0.62×
Market median
-126% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
View
PDF
More on Termino C 14642 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network